LINC00511 and central nervous system cancer: LINC00511 is also overexpressed in non–small cell lung cancer [30], pancreatic ductal adenocarcinoma [31], tongue squamous cell carcinoma [32], breast cancer [33, 34], osteosarcoma [35], glioma [36], ovarian cancer [37], and thyroid carcinoma [38].